IIV4

BIOLOGICAL3 trials

Sponsors

Vanderbilt University Medical Center, China National Biotec Group Company Limited, Duke University

Conditions

Adverse Drug EventAsthmaticInfluenza, HumanInjection Site ReactionPneumonia, PneumococcalQuality of LifeSystemic Reaction

Phase 4

Influenza Vaccine Feasibility Study in Children With Persistent Asthma

CompletedNCT02967393

Vanderbilt University Medical CenterAsthmatic

Start: 2016-10-10End: 2017-02-01Updated: 2018-04-23

Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4

CompletedNCT04559204

China National Biotec Group Company LimitedInfluenza, Human, Pneumonia, Pneumococcal

Start: 2020-09-11End: 2021-10-09Updated: 2022-08-02

Simultaneous mRNA COVID-19 and IIV4 Vaccination Study

CompletedNCT05028361

Duke UniversityAdverse Drug Event, Injection Site Reaction, Quality of Life +1

Start: 2021-10-04End: 2023-06-15Updated: 2024-03-19

Related Papers

Immunogenicity of mRNA COVID-19 vaccine with either simultaneous or sequentially administered inactivated influenza vaccines: a randomized clinical trial.

2025-12-10

Safety of Simultaneous vs Sequential mRNA COVID-19 and Inactivated Influenza Vaccines

JAMA Network Open2024-11-0611 citations